BackScopus Biopharma Overview

Scopus Biopharma Current Cash

Latest current cash for SCPS: $360K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$362097.00
68.69% YoYΔ $-794368.00 vs prior year quarter

Peer average

Loading

Scopus Biopharma Current Cash History

Loading

Scopus Biopharma vs. peers: Current Cash Comparison

Loading

Scopus Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Scopus Biopharma (SCPS) FAQ

As of the most recent data (June 2023), SCPS shows a current cash of $360K. That compares with $1.2M in the prior-year period — down 68.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SCPS's current cash is now $360K (was $1.2M) — a 68.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Scopus Biopharma is outperforming or lagging.

Tracking SCPS's current cash over time shows whether Scopus Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $360K That compares with $1.2M in the prior-year period — down 68.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Scopus Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $360K) with ownership activity and broader fundamentals.

Scopus Biopharma's current cash is $360K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.